IXICO chosen as partner for Medical Imaging & Artificial Intelligence Centre

The newly established centre brings together a consortium including London universities, NHS Trusts plus industry partners including global multinationals and UK-based SME's and the Health Innovation Network

Artificial intelligence
The centre will explore how advanced imaging and AI technologies can be used to improve medical treatment

IXICO PLC (LON:IXI) has been chosen as a small-to-medium enterprise (SME) partner in the London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare.

The data analytics company focused on delivering insights in neuroscience said the newly established centre, launched on 28 February, is part of the UK Government's Industrial Strategy Challenge Fund.

READ: IXICO gets vote of confidence from big pharma

Led by King's College London, the new Centre will develop and train sophisticated artificial intelligence algorithms from NHS medical images and patient data to provide tools for clinicians to speed up and improve diagnosis and care across a number of patient pathways including dementia, heart failure and cancer.

"We are excited to be selected to be part of this flagship UK Government initiative to ensure that UK science is at the forefront of the application and impact of artificial intelligence to the future of healthcare,” said Giulio Cerroni, the chief executive officer of IXICO.

“The development and application of artificial intelligence technology will enable IXICO to develop highly valued, innovative solutions to our biopharmaceutical clients in support of their neuroscience clinical development programmes. We are looking forward to collaborations with other leaders across this expanding field of research," he added.

Quick facts: IXICO PLC

Price: 63.6799 GBX

Market: AIM
Market Cap: £30.61 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...



IXICO PLC - Proactive One2One Virtual Event

IXICO PLC's Giulio Cerroni speaks to investors at the Proactive One2One Virtual Event. IXICO's purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.

on 10/7/20

2 min read